Evidence map›Paper›PMID 21524128›Full record

ReviewAnalytical chemistry2011

Aptamer in bioanalytical applications.

Anton B Iliuk, Lianghai Hu, W Andy Tao

Abstract readReview
In one paragraph

Review in Analytical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. APIPred: An XGBoost-Based Method for Predicting Aptamer-Protein Interactions.Journal of chemical information and modeling · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anton B IliukDepartment of Biochemistry and Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, USA.
Lianghai Hu
W Andy Tao

Funding

New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling PathwaysR01GM088317 · NIGMS · PURDUE UNIVERSITY · PI TAO, W. ANDY · 2010 to 2014
$1.6M
Proteomic Studies of Dendrimer-based NanomedicinesR21RR025802 · NCRR · PURDUE UNIVERSITY · PI TAO, W. ANDY · 2009 to 2011
$555k
NCRR NIH HHS R21 RR025802NCRR NIH HHS R21RR025802NIGMS NIH HHS R01 GM088317NIGMS NIH HHS R01GM088317
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aptamers, NucleotideBiosensing TechniquesColorimetryElectrochemical TechniquesElectrophoresis, CapillaryLuminescent MeasurementsMicrofluidicsQuantum DotsAptamers, Nucleotide

Identifiers

PMID21524128
PMCPMC3115435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.